Related Experiment Video
Updated: Mar 21, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.2K
Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.
Sarah Ghandour1, Adrien Cosinschi1, Zohra Mazouni1
1Cancer Center - Radiotherapy Department, Riviera-Chablais Hospital, Vevey, Switzerland.
Zeitschrift Fur Medizinische Physik
|May 10, 2016
Summary
Multicriteria optimization (MCO) combined with direct machine parameter optimization (DMPO) provides efficient and high-quality stereotactic body radiotherapy (SBRT) planning. This approach improves dose gradients, particularly for lung tumors, ensuring optimal treatment outcomes.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment Planning
Background:
- Stereotactic body radiotherapy (SBRT) requires precise dosimetric planning for effective tumor treatment and normal tissue sparing.
- Multicriteria optimization (MCO) offers a method to balance competing objectives in treatment planning.
- Direct machine parameter optimization (DMPO) can further refine plans for improved dose conformity.
Purpose of the Study:
- To evaluate the efficacy of combining multicriteria optimization (MCO) with direct machine parameter optimization (DMPO) for SBRT planning.
- To achieve high-quality, efficient dosimetric plans for various SBRT tumor sites.
- To fine-tune MCO-generated plans using DMPO for enhanced dose gradients.
Main Methods:
- SBRT plans were generated for 18 patients (lung, liver, adrenal cancers) using VMAT technique in RayStation™ TPS.
- Initial plans utilized MCO for efficient, balanced optimization between tumor control and normal tissue sparing.
- MCO plans were further refined using DMPO to improve dose gradients around the planning target volume (PTV).
Main Results:
- The combined MCO+DMPO approach yielded clinically optimal SBRT plans within approximately one hour of computation time.
- PTV coverage and organ-at-risk sparing were comparable between MCO and MCO+DMPO plans (p>0.05).
- MCO+DMPO significantly improved conformity indexes (CI100, CI50) compared to MCO alone (p<0.05).
Conclusions:
- MCO enables efficient convergence to optimal SBRT solutions.
- The MCO+DMPO combination enhances dose gradients, especially beneficial for lung SBRT.
- This integrated approach ensures high-quality, deliverable SBRT plans meeting clinical constraints.

